First in Human Trial of MK4827, a Poly(ADP)ribose Polymerase (PARP) Inhibitor With Antitumor Activity in BRCA Mutation Carrier and Sporadic Cancer PatientsShahneen K Sandhu,William R Schelman,George Wilding, Moreno,Richard Baird,S M C Miranda,Lucy Hylands,Ruth Riisnaes,Martin Forster,A Omlin, N Kreischer,Khin Thway,L Sun,H Gevensleben,C Toniatti,C Carpenter,R Iannone,Stan B Kaye, J Debono,R M WenhamLancet Oncology(2013)引用 23|浏览31暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要